Biological Aging, Adiposity, and Inflammation in Degenerative Spine Disease: Mendelian Randomization and Longitudinal United Kingdom Biobank Analyses.
Key claim: Leukocyte telomere length is an observational marker rather than a causal driver of degenerative spine disease, whereas adiposity and systemic inflammation are causally implicated.
Abstract
BACKGROUND: Telomere length (TL) is a marker of cumulative biological aging, but whether it causally contributes to degenerative spine disease or reflects upstream metabolic and inflammatory burden remains unclear. METHODS: We performed a population-based study integrating 2-sample Mendelian randomization with longitudinal United Kingdom Biobank analyses. Mendelian randomization used genetic instruments for leukocyte TL, body mass index (BMI), and C-reactive protein (CRP) against 5 degenerative spine genome-wide association study outcomes. We estimated direct TL effects after adjustment for BMI and CRP. Observational analyses included 265,805 United Kingdom Biobank participants of European ancestry with measured leukocyte TL and no baseline degenerative spine disease. Cox proportional hazards models adjusted for age, sex, BMI, smoking status, and Townsend deprivation index evaluated incident degenerative spine diagnoses and spine surgery. RESULTS: We found no evidence that genetically proxied TL was associated with spinal stenosis, spondylosis, disc degeneration, spondylolisthesis, or disc prolapse (all P > 0.32). In contrast, genetically proxied BMI and CRP were both associated with spinal stenosis (BMI odds ratio = 1.55, P < 0.001; CRP odds ratio = 1.49, P = 0.002) and multiple other degenerative spine outcomes. Observationally, longer TL was associated with lower risk of any degenerative spine disease (hazard ratio [HR] = 0.953, P < 0.001), lumbar stenosis (HR = 0.943, P < 0.001), lumbar decompression (HR = 0.962, P = 0.005), and all-cause mortality (HR = 0.923, P < 0.001). Short TL was associated with a higher risk of composite spine disease (HR = 1.07, P < 0.001). CONCLUSIONS: Leukocyte TL was modestly associated with incident degenerative spine disease and lumbar decompression but did not show a causal effect. TL appears to reflect cumulative biological aging rather than directly drive degenerative spine pathology.
Why this matters
[human-observational] Combining longitudinal human data with Mendelian randomization separates an aging-associated marker from candidate drivers of spinal degeneration: leukocyte telomere length lacks causal support, while adiposity and CRP-indexed systemic inflammation receive genetic-inference support. These results refine the disease-specific causal picture under Mendelian-randomization assumptions, but do not demonstrate that telomere extension, weight reduction, or anti-inflammatory treatment changes spinal disease outcomes.